New mRNA flu vaccine far more effective than existing jabs, but has some limitations, study finds

A newly developed mRNA-based flu vaccine is almost 35 per cent more effective against the most common form of influenza, according to a new study.

The phase three trial, whose results were published this morning in the New England Journal of Medicine, involved more than 18,000 people aged between 18 and 64.

Half of the participants were given a standard flu vaccine, while the other half received the new mRNA option developed by Pfizer.

To know more- https://www.9news.com.au/health/mrna-flu-vaccine-pfizer-trial-results/d7d0ba8e-9ed8-4035-95cc-882f99d38a78